Midterm outcomes of paclitaxel-eluting stents for the treatment of intracranial posterior circulation stenoses

Journal of Neurosurgery

Volumn 106, Issue 2, 2007, Pages 222-225

  Steinfort, Brendan ^a   Ng, Perry P ^a,b   Faulder, Kenneth ^a   Harrington, Timothy ^a   Grinnell, Verity ^a   Sorby, William ^a   Morgan, Michael K ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Angioplasty; Artery; Intracranial stenosis; Stent; Vertebrobasilar

Indexed keywords

ABCIXIMAB; PACLITAXEL;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CONVENTIONAL ANGIOGRAPHY; DRUG ELUTING STENT; DYSARTHRIA; FOLLOW UP; HEMIPARESIS; HUMAN; MALE; MEDICAL RECORD; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; STENOSIS; STROKE; TREATMENT OUTCOME;

ADULT; AGED; ANGIOPLASTY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; RETROSPECTIVE STUDIES; STENTS; TIME FACTORS; TREATMENT OUTCOME; TUBULIN MODULATORS; VERTEBROBASILAR INSUFFICIENCY;

EID: 33846805721     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/jns.2007.106.2.222     Document Type: Article

References (28)

1. Ausman JI, Diaz FG, Vacca DF, Sadasivan B: Superficial temporal and occipital artery bypass pedicles to superior, anterior inferior, and posterior inferior cerebellar arteries for vertebrobasilar insufficiency. J Neurosurg 72:554-558, 1990
2. Boulos AS, Agner C, Deshaies EM: Preliminary evidence supporting the safety of drug-eluting stents in neurovascular disease. Neurol Res 27 (1 Suppl):S95-S102, 2005
3. Chimowitz MI, Kokkinos J, Strong J, Brown MB, Levine SR, Silliman S, et al: The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology 45:1488-1493, 1995
4. Cirillo P, Golino P, Ragni M, Battaglia C, Pacifico F, Formisano S, et al: Activated platelets and leucocytes cooperatively stimulate smooth muscle cell proliferation and proto-oncogene expression via release of soluble growth factors. Cardiovasc Res 43:210-218, 1999
5. Dollery CM, Humphries SE, McClelland A, Latchman DS, Mc-Ewan JR: Expression of tissue inhibitor of matrix metalloproteinases 1 by use of an adenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular balloon injury. Circulation 99:3199-3205, 1999
6. EC/IC Bypass Study Group: Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. N Engl J Med 313:1191-1200, 1985
7. Farb A, Heller PF, Shroff S, Cheng L, Kolodgie FD, Carter AJ, et al: Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 104:473-479, 2001
8. Furukawa Y, Matsumori A, Ohashi N, Shioi T, Ono K, Harada A, et al: Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries. Circ Res 84:306-314, 1999
9. Gomma AH, Hirschfield GM, Gallimore JR Jr, Lowe GD, Pepys MB, Fox KM: Preprocedural inflammatory markers do not predict restenosis after successful coronary stenting. Am Heart J 147:1071-1077, 2004
10. Hopkins LN, Budny JL: Complications of intracranial bypass for vertebrobasilar insufficiency. J Neurosurg 70:207-211, 1989
11. Hopkins LN, Budny JL, Castellani D: Extracranial-intracranial arterial bypass and basilar artery ligation in the treatment of giant basilar artery aneurysms. Neurosurgery 13:189-194, 1983
12. Hopkins LN, Martin NA, Hadley MN, Spetzler RF, Budny J, Carter LP: Vertebrobasilar insufficiency. Part 2. Microsurgical treatment of intracranial vertebrobasilar disease. J Neurosurg 66:662-674, 1987
13. Lee SH, Jung JH, Shim WH: Endovascular treatment of basilar artery stenosis with drug-eluting stent: a case report and literature review. Catheter Cardiovasc Interv 64:296-300, 2005
14. Liistro F, Stankovic G, Di Mario C, Takagi T, Chieffo A, Moshiri S, et al: First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis: immediate and long-term clinical and angiographic outcome. Circulation 105:1883-1886, 2002
15. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al: Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364:1519-1521, 2004
16. Moreno PR, Palacios IF, Leon MN, Rhodes J, Fuster V, Fallon JT: Histopathologic comparison of human coronary in-stent and postballoon angioplasty restenotic tissue. Am J Cardiol 84:462-466, A469, 1999
17. Philippe F, Dibie A, Larrazet F, Meziane T, Folliguet T, Laborde E: [Drug eluting stents: from evidence based medicine to clinical practice.] Ann Cardiol Angeiol (Paris) 54:201-211, 2005 (Fr)
18. Rau M, Maikowski C, Weber M, Keil E, Elsasser A, Mollmann H, et al: Treatment of in-stent restenosis with sirolimus-elutingstents-a six month clinical and angiographic follow-up. Z Kardiol 94:742-747, 2005
19. Rectenwald JE, Moldawer LL, Huber TS, Seeger JM, Ozaki CK: Direct evidence for cytokine involvement in neointimal hyperplasia. Circulation 102:1697-1702, 2000
20. Rensing BJ, Vos J, Smits PC, Foley DP, van den Brand MJ, van der Giessen WJ, et al: Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up. Eur Heart J 22:2125-2130, 2001
21. Schwartz RS, Holmes DR Jr, Topol EJ: The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol 20:1284-1293, 1992
22. Southgate KM, Fisher M, Banning AP, Thurston VJ, Baker AH, Fabunmi RP, et al: Upregulation of basement membrane-degrading metalloproteinase secretion after balloon injury of pig carotid arteries. Circ Res 79:1177-1187, 1996
23. SSYLVIA Study Investigators: Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 35:1388-1392, 2004
24. Thijs VN, Albers GW: Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 55:490-497, 2000
25. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, et al: Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109:701-705, 2004
26. Virmani R, Liistro F, Stankovic G, Di Mario C, Montorfano M, Farb A, et al: Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans. Circulation 106:2649-2651, 2002
27. Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group: Prognosis of patients with symptomatic vertebral or basilar artery stenosis. Stroke 29:1389-1392, 1998
28. Weber W, Mayer TE, Henkes H, Kis B, Hamann GF, Schulte-Altedorneburg G, et al: Stent-angioplasty of intracranial vertebral and basilar artery stenoses in symptomatic patients. Eur J Radiol 55:231-236, 2005